Image
 Consortium of Eosinophilic Gastrointestinal Disease Researchers

Learn About CEGIR in Overview Video

November 4, 2021

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders (EGIDs). Learn more about CEGIR in this overview video

 

 


 

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). CEGIR is funded under grant number U54AI117804 as a collaboration between NCATS, the National Institute of Allergy and Infectious Diseases (NIAID), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

View News by Topic

Recent Articles

spotlight

The Newsletter of the National Institutes of Health-funded Rare Diseases Clinical Research

 

Previous Issues

October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 February 2022 November 2021 February 2021 July 2020 Subscribe